3 hours agoUS approves “Johnson & Johnson” vaccine
Periskopi(5 years ago)
(5 years ago)The U.S. Food and Bars Administration formally authorized the use of Johnson & Johnson vaccine on Saturday, paving the way for its use since Monday. According to data from a study extending to three continents, the Johnson & Johnson vaccine, taken in just one dose, is 85 percent effective against [...]
According to data from a study extending to three continents, the Johnson & Johnson vaccine, taken in just one dosage, is 85 percent effective against COVID-19 disease, caused by coronary. It also offers protection in countries where South Africa's version is spreading.
The dose of one dose has been eagerly anticipated by health officials who want to speed up vaccines in a race against the coronary and its disturbing mutations. According to Johns Hopkins University, by Saturday evening, more than 28.5 million Americans have been affected by COVID-19 and nearly 512 thousand have lost their lives.
